Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse.

McPhee CG, Duncan FJ, Silva KA, King LE Jr, Hogenesch H, Roopenian DC, Everts HB, Sundberg JP.

J Invest Dermatol. 2012 Jun;132(6):1736-8. doi: 10.1038/jid.2012.17. Epub 2012 Feb 23. No abstract available.

2.

NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.

Wu X, Lahiri A, Haines GK 3rd, Flavell RA, Abraham C.

J Immunol. 2014 Apr 1;192(7):3409-18. doi: 10.4049/jimmunol.1302436. Epub 2014 Mar 3.

3.

Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.

Dengel LT, Norrod AG, Gregory BL, Clancy-Thompson E, Burdick MD, Strieter RM, Slingluff CL Jr, Mullins DW.

J Immunother. 2010 Nov-Dec;33(9):965-74. doi: 10.1097/CJI.0b013e3181fb045d.

4.

Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.

Basset L, Chevalier S, Danger Y, Arshad MI, Piquet-Pellorce C, Gascan H, Samson M.

J Mol Med (Berl). 2015 Dec;93(12):1355-67. doi: 10.1007/s00109-015-1319-6. Epub 2015 Jul 23.

PMID:
26199110
5.

Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.

Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice LA, Colvin RA, Luster AD.

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4814-9. doi: 10.1073/pnas.0801544105. Epub 2008 Mar 17.

6.

The puzzling role of CXCR3 and its ligands in organ allograft rejection.

Halloran PF, Fairchild RL.

Am J Transplant. 2008 Aug;8(8):1578-9. doi: 10.1111/j.1600-6143.2008.02323.x. No abstract available.

7.

CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid.

Manousou P, Kolios G, Drygiannakis I, Koulentaki M, Pyrovolaki K, Voumvouraki A, Notas G, Bourikas L, Papadaki HA, Kouroumalis E.

Clin Exp Immunol. 2013 Apr;172(1):9-15. doi: 10.1111/cei.12032.

8.

Dual specificity of anti-CXCL10-CXCL9 antibodies is governed by structural mimicry.

Fagète S, Rousseau F, Magistrelli G, Gueneau F, Ravn U, Kosco-Vilbois MH, Fischer N.

J Biol Chem. 2012 Jan 6;287(2):1458-67. doi: 10.1074/jbc.M111.253658. Epub 2011 Oct 31.

9.

CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung.

Manicone AM, Burkhart KM, Lu B, Clark JG.

Exp Lung Res. 2008 Sep;34(7):391-407. doi: 10.1080/01902140802221987.

10.

Antihistaminic drug olopatadine downmodulates T cell chemotaxis toward CXCL10 by reducing CXCR3 expression, F-actin polymerization and calcium influx in patients with alopecia areata.

Ito T, Fujiyama T, Hashizume H, Tokura Y.

J Dermatol Sci. 2013 Oct;72(1):68-71. doi: 10.1016/j.jdermsci.2013.04.029. Epub 2013 May 11. No abstract available.

PMID:
23735349
11.

The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation.

Shino MY, Weigt SS, Li N, Palchevskiy V, Derhovanessian A, Saggar R, Sayah DM, Huynh RH, Gregson AL, Fishbein MC, Ardehali A, Ross DJ, Lynch JP 3rd, Elashoff RM, Belperio JA.

PLoS One. 2017 Jul 7;12(7):e0180281. doi: 10.1371/journal.pone.0180281. eCollection 2017.

12.

Characteristics of Allergic Pulmonary Inflammation in CXCR3Knockout Mice Sensitized and Challenged with House Dust Mite Protein.

Liu Z, Chen H, Chen X, Gao J, Guo Z.

PLoS One. 2016 Oct 11;11(10):e0162905. doi: 10.1371/journal.pone.0162905. eCollection 2016.

13.

CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation.

Groom JR, Richmond J, Murooka TT, Sorensen EW, Sung JH, Bankert K, von Andrian UH, Moon JJ, Mempel TR, Luster AD.

Immunity. 2012 Dec 14;37(6):1091-103. doi: 10.1016/j.immuni.2012.08.016. Epub 2012 Nov 1.

14.

CXCR3/CXCL10 Axis Shapes Tissue Distribution of Memory Phenotype CD8+ T Cells in Nonimmunized Mice.

Alanio C, Barreira da Silva R, Michonneau D, Bousso P, Ingersoll MA, Albert ML.

J Immunol. 2018 Jan 1;200(1):139-146. doi: 10.4049/jimmunol.1700564. Epub 2017 Nov 29.

PMID:
29187588
15.

Differential expression of CXCL1, CXCL9, CXCL10 and CXCL12 chemokines in alopecia areata.

Zainodini N, Hassanshahi G, Arababadi MK, Khorramdelazad H, Mirzaei A.

Iran J Immunol. 2013 Mar;10(1):40-6. doi: IJIv10i1A5.

16.

Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma.

Ohtani H, Jin Z, Takegawa S, Nakayama T, Yoshie O.

J Pathol. 2009 Jan;217(1):21-31. doi: 10.1002/path.2448.

PMID:
18980207
17.

FLI1 Levels Impact CXCR3 Expression and Renal Infiltration of T Cells and Renal Glycosphingolipid Metabolism in the MRL/lpr Lupus Mouse Strain.

Sundararaj KP, Thiyagarajan T, Molano I, Basher F, Powers TW, Drake RR, Nowling TK.

J Immunol. 2015 Dec 15;195(12):5551-60. doi: 10.4049/jimmunol.1500961. Epub 2015 Nov 4.

18.

CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase.

Ito T, Hashizume H, Shimauchi T, Funakoshi A, Ito N, Fukamizu H, Takigawa M, Tokura Y.

J Dermatol Sci. 2013 Feb;69(2):140-7. doi: 10.1016/j.jdermsci.2012.12.003. Epub 2012 Dec 26.

PMID:
23312578
19.

CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells.

Hickman HD, Reynoso GV, Ngudiankama BF, Cush SS, Gibbs J, Bennink JR, Yewdell JW.

Immunity. 2015 Mar 17;42(3):524-37. doi: 10.1016/j.immuni.2015.02.009. Epub 2015 Mar 10.

20.

[Expression and significance of chemokine CXC receptor 3, 4 and their ligands at the early pregnancy decidua and villi].

Bai XX, Kong BH, Zhang YZ, Qu X, Wang HL.

Zhonghua Fu Chan Ke Za Zhi. 2008 Dec;43(12):904-8. Chinese.

PMID:
19134328

Supplemental Content

Support Center